Well: Boosting Your Flu Shot Response

Phys Ed

Gretchen Reynolds on the science of fitness.

As this year’s influenza season continues to take its toll, those procrastinators now hurrying to get a flu shot might wish to know that exercise may amplify the flu vaccine’s effect. And for maximal potency, the exercise should be undertaken at the right time and involve the right dosage of sweat, according to several recent reports.

Flu shots are one of the best ways to lessen the risk of catching the disease. But they are not foolproof. By most estimates, the yearly flu vaccine blocks infection 50 to 70 percent of the time, meaning that some of those being inoculated gain little protection. The more antibodies someone develops, the better their protection against the flu, generally speaking. But for some reason, some people’s immune systems produce fewer antibodies to the influenza virus than others’ do.

Being physically fit has been found in many studies to improve immunity in general and vaccine response in particular. In one notable 2009 experiment, sedentary, elderly adults, a group whose immune systems typically respond weakly to the flu vaccine, began programs of either brisk walking or a balance and stretching routine. After 10 months, the walkers had significantly improved their aerobic fitness and, after receiving flu shots, displayed higher average influenza antibody counts 20 weeks after a flu vaccine than the group who had stretched.

But that experiment involved almost a year of dedicated exercise training, a prospect that is daunting to some people and, in practical terms, not helpful for those who have entered this flu season unfit.

So scientists have begun to wonder whether a single, well-calibrated bout of exercise might similarly strengthen the vaccine’s potency.

To find out, researchers at Iowa State University in Ames recently had young, healthy volunteers, most of them college students, head out for a moderately paced 90-minute jog or bike ride 15 minutes after receiving their flu shot. Other volunteers sat quietly for 90 minutes after their shot. Then the researchers checked for blood levels of influenza antibodies a month later.

Those volunteers who had exercised after being inoculated, it turned out, exhibited “nearly double the antibody response” of the sedentary group, said Marian Kohut, a professor of kinesiology at Iowa State who oversaw the study, which is being prepared for publication. They also had higher blood levels of certain immune system cells that help the body fight off infection.

To test how much exercise really is required, Dr. Kohut and Justus Hallam, a graduate student in her lab, subsequently repeated the study with lab mice. Some of the mice exercised for 90 minutes on a running wheel, while others ran for either half as much time (45 minutes) or twice as much (3 hours) after receiving a flu shot.

Four weeks later, those animals that, like the students, had exercised moderately for 90 minutes displayed the most robust antibody response. The animals that had run for three hours had fewer antibodies; presumably, exercising for too long can dampen the immune response. Interestingly, those that had run for 45 minutes also had a less robust response. “The 90-minute time point appears to be optimal,” Dr. Kohut says.

Unless, that is, you work out before you are inoculated, another set of studies intimates, and use a dumbbell. In those studies, undertaken at the University of Birmingham in England, healthy, adult volunteers lifted weights for 20 minutes several hours before they were scheduled to receive a flu shot, focusing on the arm that would be injected. Specifically, they completed multiple sets of biceps curls and side arm raises, employing a weight that was 85 percent of the maximum they could lift once. Another group did not exercise before their shot.

After four weeks, the researchers checked for influenza antibodies. They found that those who had exercised before the shot generally displayed higher antibody levels, although the effect was muted among the men, who, as a group, had responded to that year’s flu vaccine more robustly than the women had.

Over all, “we think that exercise can help vaccine response by activating parts of the immune system,” said Kate Edwards, now a lecturer at the University of Sydney, and co-author of the weight-training study.

With the biceps curls, she continued, the exercises probably induced inflammation in the arm muscles, which may have primed the immune response there.

As for 90 minutes of jogging or cycling after the shot, it probably sped blood circulation and pumped the vaccine away from the injection site and to other parts of the body, Dr. Kohut said. The exercise probably also goosed the body’s overall immune system, she said, which, in turn, helped exaggerate the vaccine’s effect.

But, she cautions, data about exercise and flu vaccines is incomplete. It is not clear, for instance, whether there is any advantage to exercising before the shot instead of afterward, or vice versa; or whether doing both might provoke the greatest response – or, alternatively, be too much and weaken response.

So for now, she says, the best course of action is to get a flu shot, since any degree of protection is better than none, and, if you can, also schedule a visit to the gym that same day. If nothing else, spending 90 minutes on a stationary bike will make any small twinges in your arm from the shot itself seem pretty insignificant.

Read More..

Rights Group Reports on Abuses of Surveillance and Censorship Technology





A Canadian human rights monitoring group has documented the use of American-made Internet surveillance and censorship technology by more than a dozen governments, some with harsh human rights policies like Syria, China and Saudi Arabia.







Jakub Dalek of the Munk School of Global Affairs.







Thor Swift for The New York Times

Morgan Marquis-Boire led the research with Mr. Dalek.






The Citizen Lab Internet research group, based at the Munk School of Global Affairs at the University of Toronto, used computer servers to scan for the distinctive signature of gear made by Blue Coat Systems of Sunnyvale, Calif.


It determined that Egypt, Kuwait, Qatar, Saudi Arabia and the United Arab Republic employed a Blue Coat system that could be used for digital censorship. The group also determined that Bahrain, China, India, Indonesia, Iraq, Kenya, Kuwait, Lebanon, Malaysia, Nigeria, Qatar, Russia, Saudi Arabia, South Korea, Singapore, Thailand, Turkey and Venezuela used equipment that could be used for surveillance and tracking.


The authors said they wanted to alert the public that there was a growing amount of surveillance and content-filtering technology distributed throughout the Internet. The technology is not restricted from export by the State Department, except to countries that are on embargo lists, like Syria, Iran and North Korea.


“Our findings support the need for national and international scrutiny of the country Blue Coat implementations we have identified, and a closer look at the global proliferation of dual-use information and communications technology,” the group noted. “We hope Blue Coat will take this as an opportunity to explain their due diligence process to ensure that their devices are not used in ways that violate human rights.”


A spokesman for Blue Coat Systems said the firm had not seen the final report and was not prepared to comment.


In 2011, several groups, including Telecomix and Citizen Labs, raised concerns that Blue Coat products were being used to find and track opponents of the Syrian government. The company initially denied that its equipment had been sold to Syria, which is subject to United States trade sanctions.


Shortly afterward, Blue Coat reversed itself and acknowledged that the systems were indeed in Syria, but it said that the devices had been shipped to a distributor in Dubai, and said that it thought that they had been destined for the Iraqi Ministry of Communications.


The Citizen Lab research project was led by Morgan Marquis-Boire and Jakub Dalek. Mr. Marquis-Boire, a Google software engineer, has during the last year been involved in a variety of research projects aimed at exposing surveillance tools used by authoritarian regimes. He said that he carefully segregated his work at Google from his human rights research.


Last year, Mr. Marquis-Boire used computer servers to identify the use of an intelligence-oriented surveillance software program, called FinSpy, which was being used by Bahrain to track opposition activists.


On a hunch last month, the researchers used the Shodan search engine, a specialized Internet tool intended to help identify computers and software services that were connected to the Internet. They were able to identify a number of the Blue Coat systems that are used for content filtering and for “deep packet inspection,” a widely used technology for detecting and controlling digital content as it travels through the Internet.


The researchers stressed that they were aware that there were both benign and harmful uses for the Blue Coat products identified as ProxySG, which functions as a Web filter, and a second system, PacketShaper, which can detect about 600 Web applications and can be used to control undesirable Web traffic.


“I’m not trying to completely demonize this technology,” Mr. Marquis-Boire said.


The researchers also noted that the equipment does not directly fall under the dual-use distinction employed by the United States government to control the sale of equipment that has both military and civilian applications, but it can be used for both political and intelligence applications by authoritarian governments.


“Syria is subject to U.S. export sanctions,” said Sarah McCune, a senior researcher at the Citizen Lab. “When it comes to other countries that aren’t subject to U.S. sanctions it’s a more difficult situation. There could still be significant human rights impact.”


The researchers also noted that a large number of American and foreign companies supplied similar gear in what Gartner, the market research firm, described as a $1.02 billion market in a report issued in May 2012.


The researchers said that some American security technology companies, like Websense, had taken strong human rights stands, but had declined to grapple with the issue of the possible misuse of the technology.


Read More..

Saving this dinosaur took a skeleton crew









The urgent message went well beyond Robert Painter's usual areas of legal expertise — personal injury, commercial disputes, medical malpractice.


In less than 48 hours, the skeleton of a Tyrannosaurus bataar, a fierce cousin of Tyrannosaurus rex, would be up for auction.


"Sorry for the late notice," the email said. "Is there anything we can do to legally stop this?"





The president of Mongolia, whom Painter had met 10 years before at a public policy conference, was now asking the Houston lawyer to block the sale of a fossil that scientists believed had been looted from the Gobi Desert. The auction catalog described the specimen:


"The quality of the preservation is superb, with wonderful bone texture and delightfully mottled grayish bone color. In striking contrast are those deadly teeth, long and frightfully robust, in a warm woody brown color, the fearsome, bristling mouth and monstrous jaws leaving one in no doubt as to how the creature came to rule its food chain."


The sheer size and condition of the fossil seemed guaranteed to fetch a seven-figure price. When Painter read the email May 18, it was already 6:30 p.m. on a Friday. The auction was Sunday.


In the days that followed, Painter, a New York auctioneer, a Texas judge, federal prosecutors, the Mongolian president and a self-described "commercial paleontologist" would come together somewhat like the skeleton they were fighting for, disparate parts brought together through dogged effort and mysterious circumstances.


The fight would play out in federal courts in a case known as United States of America vs. One Tyrannosaurus Bataar Skeleton.


***


Since 1924, the Mongolian constitution has classified dinosaur fossils as "culturally significant," meaning they cannot be taken from the country without government permission. Over the years, the punishment for illegally keeping or smuggling dinosaur bones has varied from up to seven years in prison to 500 hours of forced labor or paying up to 500,000 tugriks, the Mongolian currency. (That's about $356.50.)


Cultural heritage is a sensitive subject for a people who, their history of Genghis Khan's empire-building notwithstanding, saw powerful, aggressive neighbors invade their lands repeatedly.


After advertising for the auction caught the attention of paleontologists worldwide, Mongolian officials and journalists quickly learned of the fossil with the "delightfully mottled grayish bone color."


"The dinosaur has the color of the Gobi sand," said Oyungerel Tsedevdamba, an advisor to Mongolian President Tsakhiagiin Elbegdorj. "Such color is very particular and familiar to us and belongs to this country."


On May 18, as Tsedevdamba was preparing to leave her home in the Mongolian capital, Ulan Bator, for a meeting, her husband, a science enthusiast, pointed out a news report he'd found online: A Tyrannosaurus bataar was going to be auctioned in New York.


Auctioned fossils are usually too expensive for universities to buy, and private sellers typically don't provide enough details on how or where they got them. That leaves many of the bones in the hands of wealthy fossil buffs, or museums that look the other way.


"Technically, public institutions are neither ethically allowed to own poached specimens, nor are scientists supposed to publish on poached specimens," said Philip Currie, a University of Alberta paleontologist who studied the Gobi Desert region for 15 years. "In other words, they become scientifically useless."


The Tyrannosaurus bataar was 24 feet long, stood 8 feet high and weighed two tons. Still, the beast was only two-thirds grown when it died 70 million years ago.


Though it never grew into a 34-foot adult, the Tyrannosaurus thrived on the abundant prey attracted to the Nemegt Basin, then a lush river plain that straddled what is today the Gobi Desert on the Mongolia-China border. The carnivore's main competitors were its own kind.


The creature's jaw still carries bite marks, apparently inflicted by another Tyrannosaurus bataar.


These predators were "scrappy," Currie said. "They weren't overly playful."





Read More..

A Google-a-Day Puzzle for Jan. 15











Our good friends at Google run a daily puzzle challenge and asked us to help get them out to the geeky masses. Each day’s puzzle will task your googling skills a little more, leading you to Google mastery. Each morning at 12:01 a.m. Eastern time you’ll see a new puzzle posted here.


SPOILER WARNING:
We leave the comments on so people can work together to find the answer. As such, if you want to figure it out all by yourself, DON’T READ THE COMMENTS!


Also, with the knowledge that because others may publish their answers before you do, if you want to be able to search for information without accidentally seeing the answer somewhere, you can use the Google-a-Day site’s search tool, which will automatically filter out published answers, to give you a spoiler-free experience.


And now, without further ado, we give you…


TODAY’S PUZZLE:



Note: Ad-blocking software may prevent display of the puzzle widget.




Ken is a husband and father from the San Francisco Bay Area, where he works as a civil engineer. He also wrote the NYT bestselling book "Geek Dad: Awesomely Geeky Projects for Dads and Kids to Share."

Read more by Ken Denmead

Follow @fitzwillie and @wiredgeekdad on Twitter.



Read More..

Disney drops “Little Mermaid” re-release as 3D sales disappoint






(Reuters) – Walt Disney canceled plans for a 3D version of its 1989 animated hit “The Little Mermaid” after disappointing re-releases of “Monsters, Inc” and “Beauty and the Beast” in the format.


The film was the last of four releases for which Disney announced plans to convert some of its animated films after “The Lion King” generated domestic ticket sales of $ 94 million in 2011. “Monsters, Inc, its most recent film converted to 3D, had domestic ticket sales of only $ 30.6 million, according to the site Box Office Mojo.






Disney began 3D conversion of the underwater animated film in November, animated studio chief John Lasseter, said in interviews in November. Conversion of existing films to 3D are considered generally inexpensive and are viewed by Disney as generating publicity to boost the DVD sales of older films.


Disney said will release a fifth “Pirates of the Caribbean” movie on July 10, 2015, the studio said in an email announcing its revised release schedule.


The company said it would release two of its Marvel big-budget films in 3D next year: “Captain America: The Winter Soldier” and “Guardians of the Galaxy.”


(Reporting By Ronald Grover. Editing by Andre Grenon)


Movies News Headlines – Yahoo! News





Title Post: Disney drops “Little Mermaid” re-release as 3D sales disappoint
Url Post: http://www.news.fluser.com/disney-drops-little-mermaid-re-release-as-3d-sales-disappoint/
Link To Post : Disney drops “Little Mermaid” re-release as 3D sales disappoint
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Well: Turning to the Web for a Medical Diagnosis

Thirty-five percent of American adults said they have used the Internet to diagnose a medical condition for themselves or someone else, according to a new Pew Research Center study. Women are more likely than men to turn to the Internet for diagnoses. Other groups more likely to do so are younger people, white adults, people with college degrees and those who live in households with income above $75,000.

The study, released by Pew’s Internet and American Life Project on Tuesday, points out that Americans have always tried to answer their health questions at home, but that the Internet has expanded the options for research. Previous surveys have asked questions about online diagnoses, but the Pew study was the first to focus on the topic with a nationally representative sample, said Susannah Fox, an associate director at Pew Internet. Surveyors interviewed 3,014 American adults by telephone, from August to September 2012.

Of the one in three Americans who used the Internet for a diagnosis, about a third said they did not go to a doctor to get a professional medical opinion, while 41 percent said a doctor confirmed their diagnosis. Eighteen percent said a doctor did not agree with their diagnosis. As far as where people start when researching health conditions online, 77 percent said they started at a search engine like Google, Bing or Yahoo, while 13 percent said they began at a site that specializes in health information.

Read More..

Roche Hires Dr. John Reed to Lead Research Operations





The Swiss pharmaceutical giant Roche is turning to a prolific American academic scientist to revitalize its lagging research operations.




Dr. John C. Reed, the chief executive of the Sanford-Burnham Medical Research Institute in San Diego, will become head of Roche’s pharmaceutical research and early development group in April, the company announced Tuesday.


Dr. Reed, 54, has spent 21 years at Sanford-Burnham, formerly known as the Burnham Institute, the last 11 as chief executive.


During his tenure as chief executive, the institute grew rapidly, opened a new research site in Florida, and broadened its role from basic research to also doing drug discovery, in some cases in collaborations with pharmaceutical companies. It also received its largest donation ever, $50 million, from the credit card industry executive T. Denny Sanford, which led the institute to change its name.


Dr. Reed, 54, who holds both a medical degree and a Ph.D., is the author of more than 800 scientific papers, many dealing with why cancer cells do not commit suicide as errant cells are supposed to do. A triathlete, Dr. Reed used to get to his office around 3:30 a.m. each day, though now, with better computers, he works at home in the early hours.


“With his broad scientific and medical background, he is ideally positioned to drive Roche’s strategy of translating a better understanding of disease mechanisms into promising therapeutics,” Severin Schwan, the chief of Roche, said in a statement.


It is not unprecedented for drug companies to tap academic scientists to run research. Sanofi’s research and development is now run by Elias Zerhouni, the former director of the National Institutes of Health and professor at Johns Hopkins. Mark Fishman, a cardiologist at Harvard, was recruited to run research at Novartis, and Peter S. Kim, who heads research at Merck, was previously a biology professor at the Massachusetts Institute of Technology.


Dr. Reed, who has been on biotechnology company boards but never had a full-time corporate job, said in an interview that he was joining Roche to “have an opportunity to contribute on a larger stage, so to speak.”


At Roche he will oversee not only research but also early- and middle-stage clinical trials, something Sanford-Burnham does not do. He will supervise about 2,000 people with an annual budget in the billions, while Sanford-Burnham has about 1,200 people and a budget of around $175 million.


Dr. Reed, who will move to Basel, where Roche is based, said it was too early to discuss his agenda at Roche, other than to make its research more collaborative.


The operation Dr. Reed will run, called Pharma Research and Early Development, or pRED, does not include Genentech, the California biotechnology company that Roche fully acquired in 2009. In an effort to preserve the culture at Genentech, Roche left it autonomous, forming a group it calls gRED.


Recently, gRED has been eclipsing pRED. Roche’s three best-selling drugs, the cancer medicines Rituxan, Herceptin and Avastin, were developed at Genentech. So have some of its most attractive experimental drugs, including T-DM1, a breast cancer drug that could win regulatory approval early this year.


The organization Dr. Reed will run, by contrast, has had its share of problems in recent years. Several hundred researchers were cut in a corporate reorganization. And last year Roche discontinued development of a heart drug after it failed to work in a late-stage clinical trial.


The troubles contributed to Roche’s decision in June to shut its campus in Nutley, N.J., the birthplace of valium. At that time, Jean-Jacques Garaud, head of the Roche unit that Dr. Reed will run, left the company and was replaced on an interim basis by Mike Burgess. Roche said Tuesday that Mr. Burgess would now also leave the company.


Sanford-Burnham said that Dr. Kristiina Vuori, its president and head of its cancer center, would take over as chief executive on an interim basis. Dr. Vuori, who is originally from Finland, has worked closely with Dr. Reed.


M. Wainwright Fishburn Jr., the chairman of Sanford-Burnham, said it was “bittersweet” to see Dr. Reed leave. While the institute will lose a very successful leader, he said, the move could advance the institute’s efforts to get drug discovery work from pharmaceutical companies.


“We have one of our own in one of the most influential positions around,” he said.


Read More..

'Les Miz,' 'Argo' win big at Golden Globes, but Jodie Foster is talk of show









The epic musical “Les Miserables” dominated the 70th annual Golden Globe Awards on Sunday night with three trophies, including one for best musical or comedy. But the evening belonged to Ben Affleck.

Affleck’s political thriller “Argo,” about a CIA plot to rescue Americans trapped in Iran in 1979-80, won for best dramatic film and director for Affleck. It was a bit of vindication, perhaps, for the filmmaker, who was surprisingly absent last week when the Academy of Motion Picture Arts and Sciences announced its Oscar nominations for director.






Since the Oscar snub Thursday, Affleck has not only won a Golden Globe but he also received a Critics’ Choice Movie Award for directing as well.

PHOTOS: Golden Globes 2013 red carpet


“Les Miz” was the most honored film of the ceremony held at the Beverly Hilton Hotel’s International Ballroom and telecast live on NBC. Besides best musical or comedy, it won lead actor for Hugh Jackman, who admitted in his acceptance speech that at one point he almost quit the project after a grueling rehearsal. And Anne Hathaway sang her way to a supporting actress win as the tragic Fantine.

With her pixie haircut and tasteful white gown, Hathaway was reminiscent of a young Audrey Hepburn.

“Thank you for this lovely blunt object,” Hathaway told the Hollywood Foreign Press Assn. “I’ll forever use it as a weapon against self-doubt.”


PHOTOS: Nominees & winners | Red carpet | Best & Worst


The wins for “Les Miz” and “Argo” as well as the two Golden Globes for “Django Unchained” help give those films momentum leading to the Oscars on Feb. 24. But those honors do little to bring clarity to a topsy-turvy awards season that has seen plenty of outstanding movies to choose from — but few clear-cut front-runners.

For example, Steven Spielberg’s “Lincoln” went into the evening with seven Golden Globes nominations — more than any other film. Former President Bill Clinton even appeared to a standing ovation and thunderous applause to introduce the clip for the historical epic. But instead of “Lincoln” by a landslide, the film about the 16th president’s struggle to end the Civil War and slavery won only one honor: lead actor in a drama for Daniel Day-Lewis.

One of the most stunning moments came courtesy Jodie Foster, who took to the stage to give a ... retirement speech? A coming-out speech? It was hard to tell. She was receiving the Cecil B. DeMille Award for lifetime achievement when she ramped up to confess that she was … single. And while she seemed to take pains to sidestep addressing her sexual orientation she did thank her ex-partner and co-parent of her two boys, Cydney Bernard.


PHOTOS: Golden Globes 2013 red carpet

Her speech was also a rant in favor of privacy that brought many people to its feet. Foster noted that she has lived virtually her entire life in the public eye yet wanted to keep some things private. “I have given everything up there from the time I was 3 years old,” she said. “That is reality enough.” Even backstage, talking face-to-face with the media, she was cryptic about what, exactly, she was trying to say with her speech. (Memo to Foster: Nothing will destroy an attempt at privacy like telling the world you want to keep your life private.)

In other film awards, Jessica Chastain won lead actress in a drama for her role as a CIA operative who helps track down Osama bin Laden in “Zero Dark Thirty.” Jennifer Lawrence won lead actress in a comedy or musical for “Silver Linings Playbook” for her performance as a widow in the quirky romantic comedy. “I beat Meryl!” Lawrence joked as she accepted the trophy. (Meryl Streep was nominated in the same category, for “Hope Springs.”) Among Lawrence’s thank-yous: “Thank you, Harvey Weinstein, for killing whoever you had to kill to get me up here.”

Christoph Waltz won for supporting actor for playing a bounty hunter in Quentin Tarantino’s “Django Unchained.” The maverick filmmaker was a surprise screenplay winner for the controversial spaghetti Western set during the slavery era, beating out such favorites as the writers of “Zero Dark Thirty,” “Lincoln,” “Argo,” and “Silver Linings Playbook.”


PHOTOS: Highlights from the show


“Wow, I wasn’t expecting this,” said an effusive Tarantino. “I'm happy to be surprised.”

Austria’s “Amour” won foreign language film, and “Brave” won for animated film. Mychael Danna won for writing the score for Ang Lee’s “Life of Pi.” Original song went to pop singer Adele and Paul Epworth for “Skyfall,” the title tune for the latest James Bond installment.

On the TV side, the Golden Globes honored Showtime’s “Homeland” and HBO’s “Game Change” and "Girls" with multiple trophies.

Golden Globes 2013: List | Red Carpet | Winners | Ballot | Show moments | Quote


“Homeland,” the political thriller that counts President Obama as one of its biggest fans, won its second consecutive award for drama series. Claire Danes won her second-in-a-row Globe for lead dramatic actress in the series. Her co-star Damian Lewis took lead actor.

“Game Change,” the drama about then-Gov. Sarah Palin’s run for the vice presidency in 2008, also performed well. It snapped up three awards: miniseries or TV movie, supporting actor for Ed Harris, and lead actress for Julianne Moore for her uncanny channeling of Palin.

“Girls” won best comedy series while its young star and creator, Lena Dunham, won for lead actress. Don Cheadle won lead actor in a comedy series for Showtime’s “House of Lies.” Kevin Costner won lead actor in a miniseries or TV movie for History Channel’s “Hatfields & McCoys.” Maggie Smith won for supporting actress in a TV series, miniseries or movie for playing the acerbic dowager in PBS' “Downton Abbey.”

After a controversial three-year stint as host, Ricky Gervais turned over the emcee duties to Globe nominees Amy Poehler (“Parks & Recreation”) and Tina Fey (“30 Rock”). The pair were only slightly less irreverent, skewering Hollywood by poking fun of pill-popping Hollywood and “rat-faced” TV types and joking about the controversy surrounding Kathryn Bigelow's “Zero Dark Thirty.”

Cracked Poehler: “When it comes to torture, I trust the woman who spent three years married to James Cameron.”

ALSO:


PHOTOS: Moments from the show


VOTE: Play-at-home Globes ballot


PHOTOS: Red carpet fashion at the Golden Globes


susan.king@latimes.com and rene.lynch@latimes.com






Read More..

A Google-a-Day Puzzle for Jan. 14











Our good friends at Google run a daily puzzle challenge and asked us to help get them out to the geeky masses. Each day’s puzzle will task your googling skills a little more, leading you to Google mastery. Each morning at 12:01 a.m. Eastern time you’ll see a new puzzle posted here.


SPOILER WARNING:
We leave the comments on so people can work together to find the answer. As such, if you want to figure it out all by yourself, DON’T READ THE COMMENTS!


Also, with the knowledge that because others may publish their answers before you do, if you want to be able to search for information without accidentally seeing the answer somewhere, you can use the Google-a-Day site’s search tool, which will automatically filter out published answers, to give you a spoiler-free experience.


And now, without further ado, we give you…


TODAY’S PUZZLE:



Note: Ad-blocking software may prevent display of the puzzle widget.




Ken is a husband and father from the San Francisco Bay Area, where he works as a civil engineer. He also wrote the NYT bestselling book "Geek Dad: Awesomely Geeky Projects for Dads and Kids to Share."

Read more by Ken Denmead

Follow @fitzwillie and @wiredgeekdad on Twitter.



Read More..

French actor Depardieu sides with Putin, criticizes opposition






MOSCOW (Reuters) – French actor Gerard Depardieu, recently awarded Russian citizenship by President Vladimir Putin, has praised the former KGB spy and said his political opponents offer no real alternative.


Depardieu, who has been accused in France of abandoning his homeland to avoid a proposed 75 percent tax for millionaires, told the state-run Rossiya-24 television that Putin personified Russia’s complex and fascinating national character.






“I like this man very much, he is a very powerful political activist. He has political wisdom,” the 63-year-old star of “Cyrano de Bergerac” and “Green Card” said in comments aired late on Sunday, according to the channel’s Russian translation.


The translation was dubbed over the original French, which Rossiya-24 said would not immediately be made available.


Depardieu, who is also due in court to answer charges of crashing his scooter in Paris with more than three times the legal alcohol limit in his blood, said Putin had admitted to liking his “hooligan essence” when the two met in the Russian resort of Sochi last week.


Putin’s opponents accuse him of cracking down on dissent since his return to the presidency for a six-year third term last May. The European Union and the United States have also expressed concern that Moscow is rolling back democratic freedoms.


“The Russian opposition has no program, nothing. There are very smart people there, like (former world chess champion Garry) Kasparov, but what works well for chess is completely unsuited to politics,” Depardieu said.


Opposition activists were quick to react. Violetta Volkova, defense lawyer for several opposition members facing charges over anti-Putin protests, wrote sarcastically on Twitter: “Prominent political analyst Depardieu…”


Putin’s critics have failed to make inroads into his grip on power in over a year of protests sparked by accusations of widespread fraud in parliamentary elections in December 2011, and the presidential vote last March.


The protest movement has gradually lost steam, though tens of thousands of people marched through Moscow on Sunday to protest against a Kremlin-backed law that bans Americans from adopting Russian children.


After the protest, leftist opposition leader Sergei Udaltsov was quoted as inviting Depardieu to take part in the next anti-Putin rallies, given his interest in Russian politics.


Putin says he has developed a friendly personal relationship with Depardieu, a popular figure in Russia, where he has appeared in many advertising campaigns, including for ketchup.


(Reporting by Gabriela Baczynska; Editing by Kevin Liffey)


Movies News Headlines – Yahoo! News





Title Post: French actor Depardieu sides with Putin, criticizes opposition
Url Post: http://www.news.fluser.com/french-actor-depardieu-sides-with-putin-criticizes-opposition/
Link To Post : French actor Depardieu sides with Putin, criticizes opposition
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..